This investigation or therapeutic intervention is of limited advantage for sufferers and will be performed. In case of pT2 pN0 a taxane dependent polychemotherapy furthermore trastuzumab monotherapy is recommended which could be adopted in the event of a HR+ tumor by neratinib monotherapy for up to one year. For https://josephd197ahq4.wiki-racconti.com/user